Daewoong (003090) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Daewoong (003090) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩84.83 Billion ≈ $57.49 Million USD) by net assets (₩1.63 Trillion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 003090 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Daewoong - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Daewoong's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Daewoong Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daewoong ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhejiang Hengwei Battery Co. Ltd.
SHE:301222
N/A
Zhejiang Yueling Co Ltd
SHE:002725
0.008x
Vinci Partners Investments Ltd
NASDAQ:VINP
-0.012x
YG-1 Co. Ltd
KQ:019210
0.040x
Future Generation Global Ltd
AU:FGG
0.147x
Achieve Life Sciences Inc
NASDAQ:ACHV
-0.649x
Changzhou Langbo Seal Polytron Technologies Co Ltd Class A
SHG:603655
0.016x
Sierra Bancorp
NASDAQ:BSRR
0.034x

Annual Cash Flow Conversion Efficiency for Daewoong (2001–2024)

The table below shows the annual cash flow conversion efficiency of Daewoong from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Daewoong (003090) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩1.50 Trillion
≈ $1.02 Billion
₩162.38 Billion
≈ $110.05 Million
0.108x -24.49%
2023-12-31 ₩1.44 Trillion
≈ $973.70 Million
₩205.65 Billion
≈ $139.37 Million
0.143x +22.84%
2022-12-31 ₩1.28 Trillion
≈ $867.10 Million
₩149.08 Billion
≈ $101.03 Million
0.117x +1.23%
2021-12-31 ₩1.16 Trillion
≈ $784.11 Million
₩133.18 Billion
≈ $90.25 Million
0.115x -11.56%
2020-12-31 ₩1.12 Trillion
≈ $756.92 Million
₩145.37 Billion
≈ $98.51 Million
0.130x -3.57%
2019-12-31 ₩1.03 Trillion
≈ $695.47 Million
₩138.51 Billion
≈ $93.87 Million
0.135x +186.80%
2018-12-31 ₩964.31 Billion
≈ $653.50 Million
₩45.38 Billion
≈ $30.75 Million
0.047x -70.09%
2017-12-31 ₩939.31 Billion
≈ $636.55 Million
₩147.77 Billion
≈ $100.14 Million
0.157x +625.25%
2016-12-31 ₩864.63 Billion
≈ $585.95 Million
₩18.76 Billion
≈ $12.71 Million
0.022x -76.01%
2015-12-31 ₩828.48 Billion
≈ $561.45 Million
₩74.92 Billion
≈ $50.77 Million
0.090x +37.51%
2014-12-31 ₩708.73 Billion
≈ $480.30 Million
₩46.61 Billion
≈ $31.59 Million
0.066x -47.58%
2013-12-31 ₩687.07 Billion
≈ $465.62 Million
₩86.19 Billion
≈ $58.41 Million
0.125x +77.80%
2012-12-31 ₩391.40 Billion
≈ $265.24 Million
₩27.62 Billion
≈ $18.71 Million
0.071x +127.92%
2011-12-31 ₩336.10 Billion
≈ $227.77 Million
₩10.40 Billion
≈ $7.05 Million
0.031x -56.40%
2010-12-31 ₩484.70 Billion
≈ $328.47 Million
₩34.42 Billion
≈ $23.32 Million
0.071x -74.17%
2009-12-31 ₩429.38 Billion
≈ $290.98 Million
₩118.04 Billion
≈ $79.99 Million
0.275x +99.96%
2008-12-31 ₩412.53 Billion
≈ $279.57 Million
₩56.71 Billion
≈ $38.43 Million
0.137x +19.93%
2007-12-31 ₩363.46 Billion
≈ $246.31 Million
₩41.66 Billion
≈ $28.23 Million
0.115x -35.45%
2006-12-31 ₩294.16 Billion
≈ $199.35 Million
₩52.24 Billion
≈ $35.40 Million
0.178x +16.42%
2005-12-31 ₩251.13 Billion
≈ $170.19 Million
₩38.30 Billion
≈ $25.96 Million
0.153x -3.90%
2004-12-31 ₩222.67 Billion
≈ $150.90 Million
₩35.34 Billion
≈ $23.95 Million
0.159x +3.01%
2003-12-31 ₩213.98 Billion
≈ $145.01 Million
₩32.97 Billion
≈ $22.34 Million
0.154x -1.38%
2002-12-31 ₩205.55 Billion
≈ $139.30 Million
₩32.11 Billion
≈ $21.76 Million
0.156x -43.51%
2001-12-31 ₩228.75 Billion
≈ $155.02 Million
₩63.26 Billion
≈ $42.87 Million
0.277x --

About Daewoong

KO:003090 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$497.97 Million
₩734.81 Billion KRW
Market Cap Rank
#12411 Global
#369 in Korea
Share Price
₩17970.00
Change (1 day)
-3.96%
52-Week Range
₩16610.00 - ₩29350.00
All Time High
₩76921.40
About

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more